Such characteristics would allow circulating Pfs-IgG3 to be used as a marker for assessing the contribution of chronic exposure to malaria towards chronic, subtle morbidities that do not necessarily coincide with current parasitaemia. This evidence concerns the gene IGHG3 and malaria.